Ovarian Cancer

Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.

This trial is assessing CBX-12 as a potential treatment for ovarian cancer, with additional studies to be conducted in other solid tumor types.

From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.

A Lynparza/cediranib combo had similar results versus standalone Lynparza among patients with relapsed platinum-sensitive ovarian cancer.

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in the oncology space this week.

The past 15 months have been challenging regarding treatment for my ovarian cancer. But today, my goal is to focus on healing my mind, body and soul.

Even though my wife became quadriplegic after her breast cancer progressed, our insurance still did not help us out, so I became her caregiver full-time.

My health care team was monitoring me for cancer due to a BRCA mutation. When a hysterectomy got delayed for various reasons, I ended up with ovarian cancer.

Here are eight poems about my experience as a caregiver to my wife during her final days.

My wife faced ovarian cancer, breast cancer and multifocal motor neuropathy, and I was her only caregiver.

After leaving an unsupportive support group for ovarian cancer, I finally found my pillars of support.

Having my omentum removed after an ovarian cancer diagnosis impacted my quality of life.

The Food and Drug Administration issued six approvals for solid tumors in June, including thyroid, endometrial, colorectal, breast and ovarian cancers.

After my mom died at 50 years old, I was certain I wasn't going to reach 50. I'm glad I was wrong.

The Food and Drug Administration approved Tepylute — a liquid form of thiotepa — for the treatment of patients with breast or ovarian cancer.

Participating in research and leaning on advocacy organizations helped me through my rare cancer diagnosis.

Leaning on spiritual belief may strengthen patients' life purposes, but for many, it's common to temporarily loosen their grip on faith after a cancer diagnosis.

Seeing a young man ringing the bell surrounded by family reminded me of the incredible support I received during ovarian cancer, too.

Researchers found that adding retroperitoneal lymphadenectomy to cytoreductive surgery did not improve survival among patients with advanced ovarian cancer.

Ignoring fear and anxiety only allows them to grow until they explode into a full-blown anxiety attack. It’s okay to be scared about cancer progression.

Even after surgery and chemotherapy, I make sure to shine through cancer and any fear that stares at me.

The Food and Drug Administration granted a full approval to Elahere for the treatment of certain patients with platinum-resistant gynecologic cancers.

My genetic testing covered 648 gene variants. Of course, researchers only know the significance of a fraction of those variants.

The Food and Drug Administration green lit a first-in-human phase 1 clinical study of Innocell, a vaccine for the treatment of stage 3 and 4 ovarian cancer.

After my treatment ended for triple-negative breast cancer, I thought I was done with cancer — and then I was diagnosed with ovarian cancer.

A novel antibody drug conjugate was granted a Fast Track designation for certain patients with ovarian cancer.

As Anna “Chickadee” Cardwell from “Here Comes Honey Boo Boo” dies from cancer and former tennis player Chris Evert announces cancer diagnosis, here is what’s happening in the oncology space this week.

The Food and Drug Administration has set priority review for Elahrere as use of treatment in patients with folate receptor alpha (FRα)-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.

IRON, an artificial intelligence model, has an 80% accuracy rate of predicting therapy outcomes of patients with ovarian cancer.